Lataa...
Remdesivir: First Approval
The antiviral agent remdesivir (Veklury(®); Gilead Sciences), nucleotide analogue prodrug, has broad-spectrum activity against viruses from several families. Having demonstrated potent antiviral activity against coronaviruses in preclinical studies, remdesivir emerged as a candidate drug for the tre...
Tallennettuna:
| Julkaisussa: | Drugs |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer International Publishing
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7459246/ https://ncbi.nlm.nih.gov/pubmed/32870481 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-020-01378-w |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|